Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (NCT07824115) titled 'The Hear Clear Study' on Sept. 11.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Crossover Assignment. Primary purpose: Treatment. Masking: Single (Investigator).

Primary Sponsor: Duke University

Condition: Hearing Loss

Intervention: Other: Signal-to-Noise Ratio Enhancement (SNR+)

Recruitment Status: Not recruiting

Phase: N/A

Date of First Enrollment: January 2027

Target Sample Size: 125

Countries of Recruitment: United States

To know more, visit https://clinicaltrials.gov/study/NCT07824115

Disclaimer: Curated by HT Syndication....